| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer And GC | SVP, GC &Corporate Secretary | SVP, GC &Corporate Secretary
1 company
Reed Elizabeth E is a Chief Legal Officer And GC at TVTX. Recent filings cover 0 purchases and 56 sales. Those positions are worth an estimated $6.3M at current prices.
Our model assigns Reed Elizabeth E a middling insider score of 57/100, based on 23 past trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -13.3%.
Reed Elizabeth E's largest disclosed position is in TVTX as Chief Legal Officer And GC, worth about $6.3M. The recent filings there lean toward selling, a net 163,759 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 1,815 | $14.71 | $26,698.65 | -3.0% | -55.7% | -29.2% | |
| May 10, 2023 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 825 | $16.59 | $13,686.75 | -1.4% | -4.8% | -59.5% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 2,590 | $22.25 | $57,627.50 | -4.3% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 2,062 | $21.50 | $44,333.00 | -4.9% | -2.9% | -58.3% | |
| May 12, 2022 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 1,950 | $21.51 | $41,943.45 | -2.2% | +32.9% | -26.4% | |
| Jan 31, 2022 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 1,350 | $27.40 | $36,990.00 | -3.0% | -6.4% | -18.5% | |
| Jan 24, 2022 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 2,250 | $24.98 | $56,205.00 | -6.0% | +9.9% | -16.2% | |
| Jan 11, 2022 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 5,000 | $27.40 | $137,000.00 | -11.8% | +3.2% | -25.6% | |
| Aug 17, 2021 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 1,407 | $17.12 | $24,086.01 | -3.6% | +48.9% | +40.8% | |
| May 12, 2021 | TVTX Travere Therapeutics, Inc. | SVP, GC &Corporate Secretary | Sell | 3,250 | $19.30 | $62,725.00 | -4.4% | -27.7% | +10.6% |